(Q40699713)

22 September 2017

Combinations of dominant-negative class II transactivator, p300 or CDK9 proteins block the expression of MHC II genes (English)

1 reference

22 September 2017

Kanazawa S

1

1 reference

PubMed ID

11431425

22 September 2017

Peterlin BM

series ordinal

2

1 reference

22 September 2017

1 July 2001

1 reference

22 September 2017

International Immunology

1 reference

22 September 2017

13

1 reference

22 September 2017

951-958

1 reference

22 September 2017

7

1 reference

Regulation of MHC class II genes: lessons from a disease

22 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.7.951

Genetic evidence for a new type of major histocompatibility complex class II combined immunodeficiency characterized by a dyscoordinate regulation of HLA-D alpha and beta chains

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.7.951

Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.7.951

The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.7.951

Mouse class II transactivator: cDNA sequence and amino acid comparison with the human class II transactivator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.7.951

Complex architecture of major histocompatibility complex class II promoters: reiterated motifs and conserved protein-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.7.951

Regulation of transcription of MHC class II genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.7.951

The class II transactivator CIITA is a transcriptional integrator

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.7.951

CREB regulates MHC class II expression in a CIITA-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.7.951

Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.7.951

CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.7.951

The class II trans-activator CIITA interacts with the TBP-associated factor TAFII32

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.7.951

Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.7.951

Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.7.951

Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.7.951

Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.7.951

Cyclin K functions as a CDK9 regulatory subunit and participates in RNA polymerase II transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.7.951

Identification of multiple cyclin subunits of human P-TEFb

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.7.951

Importance of acidic, proline/serine/threonine-rich, and GTP-binding regions in the major histocompatibility complex class II transactivator: generation of transdominant-negative mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.7.951

Efficient repression of endogenous major histocompatibility complex class II expression through dominant negative CIITA mutants isolated by a functional selection strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.7.951

Suppression of MHC class II expression by human class II trans-activator constructs lacking the N-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.7.951

Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.7.951

Binding and cooperative interactions between two B cell-specific transcriptional coactivators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.7.951

Recruitment of p300/CBP in p53-dependent signal pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.7.951

Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.7.951

Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.7.951

21 January 2018

Identifiers

DOI

10.1093/INTIMM/13.7.951

1 reference

22 September 2017

1 reference

PubMed ID

11431425